Harsh K. Patel

Harsh K. Patel

Auto-generated profile, based on publicly available information

Harsh K. Patel

Midwest Digestive Health and Nutrition, Des Plaines, IL

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Cancer Letters
Verified
Journal Article
Open access
Junjie HuangJunjie Huang
Junjie Huang
HPHarsh K. Patel
Harsh K. Patel
DBDaniel Boakye
Daniel Boakye
VCViveksandeep Thoguluva Chandrasekar
Viveksandeep Thoguluva Chandrasekar
Anastasios KoulaouzidisAnastasios Koulaouzidis
Anastasios Koulaouzidis
Martin WongMartin Wong
Martin Wong
This study aimed to evaluate the global distribution, associated factors, and epidemiologic trends of gallbladder cancer (GBC) by country, sex, and age groups. The Global Cancer Observatory was interrogated for the disease burden of GBC using age-standardized rates (ASR). The prevalence of different potential risk factors for each country was extracted from Global Health Observatory and their associations with GBC incidence and mortality were examined by linear regression analysis using beta coefficients (β). The Cancer Incidence in Five Continents I-XI and the WHO Mortality database were searched and Average Annual Percent Change (AAPC) was generated from joinpoint regression analysis. The incidence (ASR = 2.3) and mortality (ASR = 1.7) of GBC varied globally in 2018 and were higher in more developed countries and among females. Countries with higher incidence had higher human development index (βmale = 0.37; βfemale = 0.27), gross domestic products (βmale = 0.13) and higher prevalence of current smoking (βfemale = 0.05), overweight (βmale = 0.02), obesity (βmale = 0.03), and hypercholesterolaemia (βmale = 0.07). Similar patterns of associations were also observed for mortality with an additional association found for diabetes (βfemale = 0.07). Although there was an overall decreasing trend in mortality, an increasing trend in incidence was observed among some populations, particularly in males (AAPCs, 8.97 to 1.92) and in younger individuals aged <50 years (AAPCs, 12.02 to 5.66). The incidence of GBC varied between countries and was related to differences in the prevalence of potential risk factors. There was an increasing incidence trend among males and younger individuals. More intensive lifestyle modifications and disease surveillance are recommended for these populations.

1 July 2024 in Annals of Internal Medicine
Verified
Journal Article
Closed access
CHCesare Hassan
Cesare Hassan
MMMasashi Misawa
Masashi Misawa
TRTommy Rizkala
Tommy Rizkala
YMYuichi Mori
Yuichi Mori
SSShahnaz Sultan
Shahnaz Sultan
CGCADx Analysis Study Group
CADx Analysis Study Group
Computer-aided diagnosis (CADx) allows prediction of polyp histology during colonoscopy, which may reduce unnecessary removal of nonneoplastic polyps. However, the potential benefits and harms of CADx are still unclear. To quantify the benefit and harm of using CADx in colonoscopy for the optical diagnosis of small (≤5-mm) rectosigmoid polyps. Medline, Embase, and Scopus were searched for articles published before 22 December 2023. Histologically verified diagnostic accuracy studies that evaluated the real-time performance of physicians in predicting neoplastic change of small rectosigmoid polyps without or with CADx assistance during colonoscopy. The clinical benefit and harm were estimated on the basis of accuracy values of the endoscopist before and after CADx assistance. The certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework. The outcome measure for benefit was the proportion of polyps predicted to be nonneoplastic that would avoid removal with the use of CADx. The outcome measure for harm was the proportion of neoplastic polyps that would be not resected and left in situ due to an incorrect diagnosis with the use of CADx. Histology served as the reference standard for both outcomes. Ten studies, including 3620 patients with 4103 small rectosigmoid polyps, were analyzed. The studies that assessed the performance of CADx alone (9 studies; 3237 polyps) showed a sensitivity of 87.3% (95% CI, 79.2% to 92.5%) and specificity of 88.9% (CI, 81.7% to 93.5%) in predicting neoplastic change. In the studies that compared histology prediction performance before versus after CADx assistance (4 studies; 2503 polyps), there was no difference in the proportion of polyps predicted to be nonneoplastic that would avoid removal (55.4% vs. 58.4%; risk ratio [RR], 1.06 [CI, 0.96 to 1.17]; moderate-certainty evidence) or in the proportion of neoplastic polyps that would be erroneously left in situ (8.2% vs. 7.5%; RR, 0.95 [CI, 0.69 to 1.33]; moderate-certainty evidence). The application of optical diagnosis was only simulated, potentially altering the decision-making process of the operator. Computer-aided diagnosis provided no incremental benefit or harm in the management of small rectosigmoid polyps during colonoscopy. European Commission. (PROSPERO: CRD42023402197).

1 March 2021 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
HPHarsh K. Patel
Harsh K. Patel
VCViveksandeep Thoguluva Chandrasekar
Viveksandeep Thoguluva Chandrasekar
SSSachin Srinivasan
Sachin Srinivasan
SPSuchi K. Patel
Suchi K. Patel
CDChandra S. Dasari
Chandra S. Dasari
PSPrateek Sharma
Prateek Sharma

13 January 2021 in Applied Network Science
Verified
Journal Article
Open access
PDF file
RPRohan Patil
Rohan Patil
RDRaviraj Dave
Raviraj Dave
HPHarsh Patel
Harsh Patel
VSViraj M. Shah
Viraj M. Shah
DCDeep Chakrabarti
Deep Chakrabarti
Udit BhatiaUdit Bhatia
Udit Bhatia
Background: The dense social contact networks and high mobility in congested urban areas facilitate the rapid transmission of infectious diseases. Typical mechanistic epidemiological models are either based on uniform mixing with ad-hoc contact processes or need real-time or archived population mobility data to simulate the social networks. However, the rapid and global transmission of the novel coronavirus (SARS-CoV-2) has led to unprecedented lockdowns at global and regional scales, leaving the archived datasets to limited use.Findings: While it is often hypothesized that population density is a significant driver in disease propagation, the disparate disease trajectories and infection rates exhibited by the different cities with comparable densities require a high-resolution description of the disease and its drivers. In this study, we explore the impact of creation of containment zones on travel patterns within the city. Further, we use a dynamical network-based infectious disease model to understand the key drivers of disease spread at sub-kilometer scales demonstrated in the city of Ahmedabad, India, which has been classified as a SARS-CoV-2 hotspot. We find that in addition to the contact network and population density, road connectivity patterns and ease of transit are strongly correlated with the rate of transmission of the disease. Given the limited access to real-time traffic data during lockdowns, we generate road connectivity networks using open-source imageries and travel patterns from open-source surveys and government reports. Within the proposed framework, we then analyze the relative merits of social distancing, enforced lockdowns, and enhanced testing and quarantining mitigating the disease spread.Scope: Our results suggest that the declaration of micro-containment zones within the city with high road network density combined with enhanced testing can help in containing the outbreaks until clinical interventions become available.

7 February 2022 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
HPHarsh K. Patel
Harsh K. Patel
RKRosemary Kovacic
Rosemary Kovacic
VCViveksandeep Thoguluva Chandrasekar
Viveksandeep Thoguluva Chandrasekar
SPSneha C. Patel
Sneha C. Patel
MSMunraj Singh
Munraj Singh
JSJanak N. Shah
Janak N. Shah

17 September 2021 in Mayo Clinic Proceedings
Verified
Journal Article
Open access
AGAashish Gupta
Aashish Gupta
SKSergey M. Kachur
Sergey M. Kachur
JTJose D. Tafur
Jose D. Tafur
HPHarsh K. Patel
Harsh K. Patel
DTDivina O. Timme
Divina O. Timme
CLCarl J Lavie
Carl J Lavie
To evaluate clinical characteristics of patients admitted to the hospital with coronavirus disease 2019 (COVID-19) in Southern United States and development as well as validation of a mortality risk prediction model. Southern Louisiana was an early hotspot during the pandemic, which provided a large collection of clinical data on inpatients with COVID-19. We designed a risk stratification model to assess the mortality risk for patients admitted to the hospital with COVID-19. Data from 1673 consecutive patients diagnosed with COVID-19 infection and hospitalized between March 1, 2020, and April 30, 2020, was used to create an 11-factor mortality risk model based on baseline comorbidity, organ injury, and laboratory results. The risk model was validated using a subsequent cohort of 2067 consecutive hospitalized patients admitted between June 1, 2020, and December 31, 2020. The resultant model has an area under the curve of 0.783 (95% CI, 0.76 to 0.81), with an optimal sensitivity of 0.74 and specificity of 0.69 for predicting mortality. Validation of this model in a subsequent cohort of 2067 consecutively hospitalized patients yielded comparable prognostic performance. We have developed an easy-to-use, robust model for systematically evaluating patients presenting to acute care settings with COVID-19 infection.